A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma.
暂无分享,去创建一个
L. Qin | C. Antonescu | S. Singer | J. Erinjeri | C. Kelly | C. Ariyan | W. Tap | M. Gounder | P. Chi | A. Crago | R. Munhoz | M. Dickson | M. Keohan | T. Bowler | Sinchun Hwang | S. D’Angelo | M. Condy | Reena Dholakia | Sam S. Yoon | Ping Chi